"Samson Clinical is setting new milestones in the rediscovery of Loniten by developing low dose oral minoxidil."

- Professor Rodney Sinclair - Founder & key opinion Leader

Samson Clinical

Publications

The objective of the 2022 ISHRS Practice Census was to gather reliable statistics with regard to the volume of hair restoration procedures.

Minoxidil is an approved medication for severe hypertension androgenetic alopecia.

Low-dose oral minoxidil (LDOM) is being increasingly prescribed off-label as an adjunct treatment for alopecia.

The advent of low-dose oral minoxidil (LDOM) has revolutionized AGA management.

We sought to examine for potential BP changes in AGA patients by age and sex.

“Response to ‘Low-dose oral minoxidil for androgenetic alopecia is not associated with clinically significant blood-pressure changes."

The average person can lose as many as 100 hairs per day. Excessive hair loss (also known as alopecia) affects men and women.

SAMSON CLINICAL

Have any questions?